Difference between revisions of "SOX11"

From Libre Pathology
Jump to navigation Jump to search
(Starter)
 
(other references)
 
Line 2: Line 2:


==Positive==
==Positive==
*[[Mantle cell lymphoma]]
*Lymphomas:
*[[Merkel cell carcinoma]]<ref name=pmid36745184>{{cite journal |vauthors=Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP |title=SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma |journal=Arch Pathol Lab Med |volume=147 |issue=7 |pages=758–766 |date=July 2023 |pmid=36745184 |doi=10.5858/arpa.2022-0238-OA |ur=}}
**[[Mantle cell lymphoma]]<ref name=pmid17934069>{{cite journal |vauthors=Ek S, Dictor M, Jerkeman M, Jirström K, Borrebaeck CA |title=Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma |journal=Blood |volume=111 |issue=2 |pages=800–5 |date=January 2008 |pmid=17934069 |doi=10.1182/blood-2007-06-093401 |url=}}</ref> (prognostic significance initially described in <ref name=pmid18729857>{{cite journal |vauthors=Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, Sander B |title=The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival |journal=Br J Haematol |volume=143 |issue=2 |pages=248–52 |date=October 2008 |pmid=18729857 |doi=10.1111/j.1365-2141.2008.07329.x |url=}}</ref> not borne out by subsequent studies)
**[[Burkitt's lymphoma]]<ref name=pmid19880779>{{cite journal |vauthors=Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadström T, Borrebaeck C |title=Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma |journal=Haematologica |volume=94 |issue=11 |pages=1563–8 |date=November 2009 |pmid=19880779 |pmc=2770967 |doi=10.3324/haematol.2009.008474 |url=}}</ref>
**[[Lymphoblastic lymphoma]]<ref name=pmid19880779></ref>
*[[Merkel cell carcinoma]]<ref name=pmid36745184>{{cite journal |vauthors=Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP |title=SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma |journal=Arch Pathol Lab Med |volume=147 |issue=7 |pages=758–766 |date=July 2023 |pmid=36745184 |doi=10.5858/arpa.2022-0238-OA |ur=}}</ref>


==References==
==References==

Latest revision as of 20:27, 1 October 2023

SOX11 immunostain.

Positive

References

  1. "Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma". Blood 111 (2): 800–5. January 2008. doi:10.1182/blood-2007-06-093401. PMID 17934069.
  2. "The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival". Br J Haematol 143 (2): 248–52. October 2008. doi:10.1111/j.1365-2141.2008.07329.x. PMID 18729857.
  3. 3.0 3.1 "Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma". Haematologica 94 (11): 1563–8. November 2009. doi:10.3324/haematol.2009.008474. PMC 2770967. PMID 19880779. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770967/.
  4. "SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma". Arch Pathol Lab Med 147 (7): 758–766. July 2023. doi:10.5858/arpa.2022-0238-OA. PMID 36745184.